1
|
Wang T, Girgis S, Chang HJ, Assi A, Fagan-Garcia K, Cromarty T, Munday R, Goodman KJ, Veldhuyzen van Zanten S. Changes in Gastric Pathology after H. pylori Treatment in Community-Driven Research Aimed at Gastric Cancer Prevention. Cancers (Basel) 2023; 15:3950. [PMID: 37568765 PMCID: PMC10417032 DOI: 10.3390/cancers15153950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Revised: 07/22/2023] [Accepted: 07/26/2023] [Indexed: 08/13/2023] Open
Abstract
Community-driven projects have characterized Helicobacter pylori (Hp) infection in Indigenous communities in the Northwest Territories (NT) and Yukon (YT), Canada. These projects address concerns about the frequent diagnosis of Hp infection among community members and its relation to gastric cancer deaths, perceived to occur with alarming frequency in this region. Projects included breath-test screening for Hp infection, gastroscopy with gastric biopsies, and treatment to eliminate Hp infection. Previous project results showed a high prevalence of stomach pathologies associated with increased cancer risk among Hp-positive participants at baseline. This analysis describes changes in precancerous gastric pathologies in project participants who had gastroscopy before baseline treatment during 2008-2013 and again in 2017. Throughout the study period, the same pathologist graded Hp density, active gastritis, chronic gastritis, atrophic gastritis, and intestinal metaplasia using the updated Sydney System. Of 310 participants from three communities with baseline pathology data, 69 had follow-up pathology data. Relative to baseline, the prevalence of Hp infection and precancerous gastric pathology was substantially lower at follow-up; most participants who were Hp-positive at baseline and Hp-negative at follow-up had reduced severity of active, chronic, and/or atrophic gastritis at follow-up. Though follow-up numbers are small, these results yield evidence that successful Hp treatment has the potential to reduce the risk of gastric cancer in Arctic Indigenous communities.
Collapse
Affiliation(s)
- Ting Wang
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | - Safwat Girgis
- Department of Lab Medicine & Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada
| | - Hsiu-Ju Chang
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | - Ali Assi
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | - Katharine Fagan-Garcia
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | - Taylor Cromarty
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | - Rachel Munday
- Susie Husky Health Centre, Aklavik, NT X0E 0A0, Canada
| | - Karen J. Goodman
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | - Sander Veldhuyzen van Zanten
- Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2X8, Canada (the CANHelp Working Group)
| | | |
Collapse
|
2
|
Nadeau L, Gaulin D, Johnson-Lafleur J, Levesque C, Fraser S. The challenges of decolonising participatory research in indigenous contexts: the Atautsikut community of practice experience in Nunavik. Int J Circumpolar Health 2022; 81:2087846. [PMID: 35979584 PMCID: PMC9397418 DOI: 10.1080/22423982.2022.2087846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Historically, research involving Indigenous peoples has been the scene of power imbalances between Indigenous communities and researchers. Indigenous peoples have often been put in the position of passive subjects of research rather than participants or collaborators with agency, a situation that the current movement of decolonisation of research and practices in the field of Indigenous health aims to counteract. Participatory research seeks a better balance of input, decision-making and power between research participants and research teams and values participants’ knowledges. As such, it is a particularly relevant approach for researchers to involve community members and support self-determination of Indigenous people. Yet, if its explicit intentions are aiming at a decolonising approach, the socio-structural context of participatory research initiatives in Indigenous communities brings obstacles to the approach’s success. The development and implementation of the participatory project Atautsikut: A Community of Practice in Youth Mental Health and Wellness in Nunavik, has been an occasion to document certain barriers that take place in participatory research. This article describes Atautsikut as a starting point for a reflection on the challenges of decolonising participatory research. It discusses how, despite intentions, structural barriers, blind spots and unexpected contextual elements may challenge the journey towards decolonising research.
Collapse
Affiliation(s)
- Lucie Nadeau
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Dominique Gaulin
- École de travail social, Université de Montréal, Montreal, QC, Canada
| | | | | | - Sarah Fraser
- Department of Psychoeducation, Université de Montréal, Montreal, QC, Canada
| |
Collapse
|
3
|
Zare Jeddi M, Virgolino A, Fantke P, Hopf NB, Galea KS, Remy S, Viegas S, Mustieles V, Fernandez MF, von Goetz N, Vicente JL, Slobodnik J, Rambaud L, Denys S, St-Amand A, Nakayama SF, Santonen T, Barouki R, Pasanen-Kase R, Mol HGJ, Vermeire T, Jones K, Silva MJ, Louro H, van der Voet H, Duca RC, Verhagen H, Canova C, van Klaveren J, Kolossa-Gehring M, Bessems J. A human biomonitoring (HBM) Global Registry Framework: Further advancement of HBM research following the FAIR principles. Int J Hyg Environ Health 2021; 238:113826. [PMID: 34583227 DOI: 10.1016/j.ijheh.2021.113826] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Revised: 07/30/2021] [Accepted: 08/06/2021] [Indexed: 11/18/2022]
Abstract
Data generated by the rapidly evolving human biomonitoring (HBM) programmes are providing invaluable opportunities to support and advance regulatory risk assessment and management of chemicals in occupational and environmental health domains. However, heterogeneity across studies, in terms of design, terminology, biomarker nomenclature, and data formats, limits our capacity to compare and integrate data sets retrospectively (reuse). Registration of HBM studies is common for clinical trials; however, the study designs and resulting data collections cannot be traced easily. We argue that an HBM Global Registry Framework (HBM GRF) could be the solution to several of challenges hampering the (re)use of HBM (meta)data. The aim is to develop a global, host-independent HBM registry framework based on the use of harmonised open-access protocol templates from designing, undertaking of an HBM study to the use and possible reuse of the resulting HBM (meta)data. This framework should apply FAIR (Findable, Accessible, Interoperable and Reusable) principles as a core data management strategy to enable the (re)use of HBM (meta)data to its full potential through the data value chain. Moreover, we believe that implementation of FAIR principles is a fundamental enabler for digital transformation within environmental health. The HBM GRF would encompass internationally harmonised and agreed open access templates for HBM study protocols, structured web-based functionalities to deposit, find, and access harmonised protocols of HBM studies. Registration of HBM studies using the HBM GRF is anticipated to increase FAIRness of the resulting (meta)data. It is also considered that harmonisation of existing data sets could be performed retrospectively. As a consequence, data wrangling activities to make data ready for analysis will be minimised. In addition, this framework would enable the HBM (inter)national community to trace new HBM studies already in the planning phase and their results once finalised. The HBM GRF could also serve as a platform enhancing communication between scientists, risk assessors, and risk managers/policy makers. The planned European Partnership for the Assessment of Risk from Chemicals (PARC) work along these lines, based on the experience obtained in previous joint European initiatives. Therefore, PARC could very well bring a first demonstration of first essential functionalities within the development of the HBM GRF.
Collapse
Affiliation(s)
- Maryam Zare Jeddi
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
| | - Ana Virgolino
- Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal
| | - Peter Fantke
- Quantitative Sustainability Assessment, Department of Technology, Management and Economics, Technical University of Denmark, Produktionstorvet 424, 2800, Kgs. Lyngby, Denmark
| | - Nancy B Hopf
- Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Epalinges, Switzerland
| | - Karen S Galea
- IOM - Institute of Occupational Medicine, Edinburgh, EH14 4AP, UK
| | - Sylvie Remy
- VITO - Flemish Institute for Technological Research, Health Unit, Mol, Belgium
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), 1169-056, Lisbon, Portugal; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1500-310, Lisboa, Portugal
| | - Vicente Mustieles
- University of Granada, Center for Biomedical Research (CIBM), Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain
| | - Mariana F Fernandez
- University of Granada, Center for Biomedical Research (CIBM), Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain
| | | | - Joana Lobo Vicente
- EEA - European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen K, Denmark
| | - Jaroslav Slobodnik
- NORMAN Association, Rue Jacques Taffanel - Parc Technologique ALATA, 60550 Verneuil-en-Halatte, France
| | - Loïc Rambaud
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Sébastien Denys
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Annie St-Amand
- Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada
| | - Shoji F Nakayama
- Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Japan
| | - Tiina Santonen
- FIOH-Finnish Institute of Occupational Health, P.O. Box 40, FI-00032, Työterveyslaitos, Finland
| | - Robert Barouki
- Université de Paris, Inserm Unit 1124, 45 rue des Saints Pères, 75006, Paris, France
| | - Robert Pasanen-Kase
- SECO - State Secretariat for Economic Affairs, Labour Directorate Section Chemicals and Work (ABCH), Switzerland
| | - Hans G J Mol
- Wageningen Food Safety Research (WFSR) - part of Wageningen University & Research, Wageningen, The Netherlands
| | - Theo Vermeire
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | - Kate Jones
- HSE - Health and Safety Executive, Harpur Hill, Buxton, SK17 9JN, UK
| | - Maria João Silva
- INSA - National Institute of Health Dr. Ricardo Jorge, Portugal; TOXOMICS - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Portugal
| | - Henriqueta Louro
- INSA - National Institute of Health Dr. Ricardo Jorge, Portugal; TOXOMICS - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Portugal
| | - Hilko van der Voet
- Wageningen University & Research, Biometris, Wageningen, the Netherlands
| | - Radu-Corneliu Duca
- Unit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, National Health Laboratory, Dudelange, Luxembourg; Centre Environment and Health, Department of Public Health and Primary Care, KU Leuven, Belgium
| | - Hans Verhagen
- University of Ulster, Coleraine, Northern Ireland, UK; Technical University of Denmark, Lyngby, Denmark
| | - Cristina Canova
- Unit of Biostatistics, Epidemiology, and Public Health-University of Padua, Padua, Italy
| | - Jacob van Klaveren
- National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
| | | | - Jos Bessems
- VITO - Flemish Institute for Technological Research, Health Unit, Mol, Belgium
| |
Collapse
|